Abstract:Genetic and biochemical studies have provided convincing evidence that the 5' noncoding region (5' NCR) of hepatitis C virus (HCV) is highly conserved among viral isolates worldwide and that translation of HCV is directed by an internal ribosome entry site (IRES) located within the 5' NCR. We have investigated inhibition of HCV gene expression using antisense oligonucleotides complementary to the 5' NCR, translation initiation codon, and core protein coding sequences. Oligonucleotides were evaluated for activity after treatment of a human hepatocyte cell line expressing the HCV 5' NCR, core protein coding sequences, and the majority of the envelope gene (E1). More than 50 oligonucleotides were evaluated for inhibition of HCV RNA and protein expression. Two oligonucleotides, ISIS 6095, targeted to a stem-loop structure within the 5' NCR known to be important for IRES function, and ISIS 6547, targeted to sequences spanning the AUG used for initiation of HCV polyprotein translation, were found to be the most effective at inhibiting HCV gene expression. ISIS 6095 and 6547 caused concentration-dependent reductions in HCV RNA and protein levels, with 50% inhibitory concentrations of 0.1 to 0.2 microM. Reduction of RNA levels, and subsequently protein levels, by these phosphorothioate oligonucleotides was consistent with RNase H cleavage of RNA at the site of oligonucleotide hybridization. Chemically modified HCV antisense phosphodiester oligonucleotides were designed and evaluated for inhibition of core protein expression to identify oligonucleotides and HCV target sequences that do not require RNase H activity to inhibit expression. A uniformly modified 2'-methoxyethoxy phosphodiester antisense oligonucleotide complementary to the initiator AUG reduced HCV core protein levels as effectively as phosphorothioate oligonucleotide ISIS 6095 but without reducing HCV RNA levels. Results of our studies show that HCV gene expression is reduced by antisense oligonucleotides and demonstrate that it is feasible to design antisense oligonucleotide inhibitors of translation that do not require RNase H activation. The data demonstrate that chemically modified antisense oligonucleotides can be used as tools to identify important regulatory sequences and/or structures important for efficient translation of HCV.

Comparison of the Anti-Hbv Effect of Various Antisense Oligodeoxynucleotides

[Antisense oligodeoxynucleotides: the certain but limited efficacy and the uncovering mechanisms for the cure of chronic hepatitis B]

Inhibition of Hepatitis B Virus Gene Expression by Single and Dual Small Interfering RNA Treatment

Experimental Study of Inhibition of Hepatitis B by Dual-Target Antisense RNA

[Cationic liposomes enhance the inhibitory effects of antisense oligodeoxynucleotide on hepatitis B virus].

[Effect of HBx Antisense Oligodeoxynucleotide on Formation of Transplanted Hepatocellular Carcinoma in Nude Mice].

lnhibition of hepatitis B virus by retroviral vectors expressing antisense RNA

Inhibitory Effects of Antisense Oligodeoxynucleotide on Replication and Expression of HDV Genome in Vitro and in Vivo

[Antiviral Effects of Dual-Target Antisense Rna: an Experimental Study with Hepatitis B Virus Transgenic Mice].

Combination of Small Interfering RNAs Mediates Greater Inhibition of Human Hepatitis B Virus Replication and Antigen Expression

INHIBITION OF HEPATITIS B VIRUS BY COMBINED Sirnas IN VITRO

[Study on Inhibitory Effect of CpG-ODN on HBV Replication in Vitro].

Effective Inhibition of Expression of Hepatitis B Virus Genes by DNAzymes.

An Aptamer Targets Hbv Core Protein And Suppresses Hbv Replication In Hepg2.2.15 Cells

Design, synthesis, and biological evaluation of novel (E)-1-arylethan-1-one O-((3-arylisoxazol-5-yl) methyl) oxime derivatives as potent non-nucleoside HBV inhibitors

[Inhibition of HBsAg and HBeAg Secretion by RNA Interference of the Polymerase Gene Sequence of Hepatitis B Virus: an Experimental Study].

Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes

Anti -hepatitis activity comparison between extracted and recombinant high mobility group chromosal protein N2

Effects of CpG oligodeoxynucleotides on enhancing immune response in patients infected with hepatitis B virus

Synthesis, Characterization and Biological Activity of A Niobium-Substituted-Heteropolytungstate on Hepatitis B Virus

Anti-Hbv Effects of Cpg Oligodeoxynucleotide-Activated Peripheral Blood Mononuclear Cells from Patients with Chronic Hepatitis B